Ziphius is a self-amplifying RNA company developing vaccines for infectious diseases and gene supplementation therapies, aiming to create a new generation of medical tools.
Our Pipeline
Z009
Chlamydia trachomatis
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Z009
Chlamydia trachomatis
Z010
Pan Corona
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Z010
Pan Corona
Z005
Cystic Fibrosis
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Z005
Cystic Fibrosis
Z008
Oncology
Program
Indication
Discovery
Preclinical
Phase 1
Phase 2
Phase 3
Z008
Oncology
Partnering
Product Partnering
Partnerships with Ziphius can be made to develop LNP-encapsulated sa-RNA-based therapeutics through out-licensing or risk-sharing models.
Technology Partnering
Ziphius seeks collaborations to explore its various platform technologies in various disease areas.